EPH Receptor A2 Antikörper
-
- Target Alle EPH Receptor A2 (EPHA2) Antikörper anzeigen
- EPH Receptor A2 (EPHA2)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser EPH Receptor A2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Verwendungszweck
- EphA2 Antibody
- Aufreinigung
- Ascitic fluid
- Immunogen
- Purified recombinant fragment of EphA2 expressed in E. Coli.
- Klon
- 1B3C7
- Isotyp
- IgM
- Top Product
- Discover our top product EPHA2 Primärantikörper
-
-
- Applikationshinweise
- ELISA: 1/10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 12, Issue 2, pp. 353-60, (2006) (PubMed).
: "EphA2 as a target for ovarian cancer therapy." in: Expert opinion on therapeutic targets, Vol. 9, Issue 6, pp. 1179-87, (2005) (PubMed).
: "
-
Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 12, Issue 2, pp. 353-60, (2006) (PubMed).
-
- Target
- EPH Receptor A2 (EPHA2)
- Andere Bezeichnung
- EphA2 (EPHA2 Produkte)
- Synonyme
- ARCC2 antikoerper, CTPA antikoerper, CTPP1 antikoerper, CTRCT6 antikoerper, ECK antikoerper, epha2 antikoerper, MGC89505 antikoerper, AW545284 antikoerper, Eck antikoerper, Myk2 antikoerper, Sek-2 antikoerper, Sek2 antikoerper, id:ibd5152 antikoerper, rtk6 antikoerper, G42 antikoerper, XE10 antikoerper, epha2-A antikoerper, EPH receptor A2 antikoerper, Eph receptor A2 antikoerper, epoxide hydrolase antikoerper, eph receptor A2 a antikoerper, EPH receptor A2 L homeolog antikoerper, EPHA2 antikoerper, Epha2 antikoerper, epha2 antikoerper, ephA2 antikoerper, epha2a antikoerper, epha2.L antikoerper
- Hintergrund
-
Description: EPH receptor A2 (EphA2), with 976-amino acid protein (about 107 kDa), belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EphA1, EphA2, EphA3, EphA4, EphA5, EphA6, EphA7, EphA8, EphA10, EphB1, EphB2, EphB3, EphB4 and EphB6 are Eph family receptors for Ephrin family ligands. In normal cells, EphA2 negatively regulates cell growth and invasiveness. EphA2 is overexpressed by many human cancers, and is often associated with poor prognostic features. The clinical significance of the expression of EphA2 was observed in breast, prostate, colon, skin, cervical, ovarian, and lung cancers.EphA2 may serve as a novel target for bladder cancer, colonic adenocarcinoma and ovarian cancer therapy.
Aliases: ECK, EPHA2
- Gen-ID
- 1969
- HGNC
- 1969
- UniProt
- P29317
- Pathways
- RTK Signalweg
-